BAFF: a local and systemic target in autoimmune diseases
In Clinical and Developmental Immunology, 2008
... Serum anti-TPO antibody, TSH, and free T4 levels were examined prior to therapy and six months after the start of therapy using commercially available ECLIA kits (MBL, Nagoya, Japan and Eiken, ...
Is ITP a thrombophilic disorder?
Vicenza, Italy. In Am J Hematol, Jan 2016
Stemming from the interest for the safety of thrombopoietin-receptor agonists (TPO-ra) romiplostim and eltrombopag, recent data have investigated if thrombotic risk is also increased in this disorder.
Novel functions of platelets in the liver.
Tsukuba, Japan. In J Gastroenterol Hepatol, Jan 2016
Thrombocytopenia, which is frequently observed in patients with chronic liver disease (CLD) and cirrhosis, is due to various causes, such as decreased thrombopoietin production and accelerated platelet destruction caused by hypersplenism; however, the relationship between thrombocytopenia and hepatic pathogenesis and the role of platelets in CLD are poorly understood.